275 related articles for article (PubMed ID: 15603891)
41. Human immune response towards recombinant Helicobacter pylori urease and cellular fractions.
Voland P; Zeitner M; Hafsi N; Prinz C
Vaccine; 2006 May; 24(18):3832-9. PubMed ID: 16122847
[TBL] [Abstract][Full Text] [Related]
42. Genetic immunization of ducks for production of antibodies specific to Helicobacter pylori UreB in egg yolks.
Kazimierczuk K; Cova L; Ndeboko B; Szczyrk U; Targosz A; Brzozowski T; Sirko A
Acta Biochim Pol; 2005; 52(1):261-6. PubMed ID: 15827623
[TBL] [Abstract][Full Text] [Related]
43. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
44. Induction of a Th17 cell response by Helicobacter pylori Urease subunit B.
Zhang JY; Liu T; Guo H; Liu XF; Zhuang Y; Yu S; Chen L; Wu C; Zhao Z; Tang B; Luo P; Mao XH; Guo G; Shi Y; Zou QM
Immunobiology; 2011 Jul; 216(7):803-10. PubMed ID: 21269729
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
46. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
[TBL] [Abstract][Full Text] [Related]
47. Oral immunization against Helicobacter pylori--a future concept.
Michetti P
J Gastroenterol; 1998; 33 Suppl 10():66-8. PubMed ID: 9840022
[TBL] [Abstract][Full Text] [Related]
48. Identification of H-2d restricted Th epitopes in Urease B subunit of Helicobacter pylori.
Shi Y; Wu C; Zhou WY; Mao XH; Guo G; Zou QM
Vaccine; 2007 Mar; 25(14):2583-90. PubMed ID: 17240487
[TBL] [Abstract][Full Text] [Related]
49. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
Nomura S; Suzuki H; Masaoka T; Kurabayashi K; Ishii H; Kitajima M; Nomoto K; Hibi T
Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
[TBL] [Abstract][Full Text] [Related]
50. Food-grade expression of Helicobacter pylori ureB subunit in Lactococcus lactis and its immunoreactivity.
Chen S; Zhang R; Duan G; Shi J
Curr Microbiol; 2011 Jun; 62(6):1726-31. PubMed ID: 21431835
[TBL] [Abstract][Full Text] [Related]
51. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection.
Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX
Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
53. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of immune prophylaxis of recombinant urease subunit of Helicobacter pylori].
Shi L; Wang J; Chen Y
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):811-5. PubMed ID: 11218872
[TBL] [Abstract][Full Text] [Related]
55. Outer membrane vesicles from genetically engineered
Liu Q; Shang Y; Shen L; Yu X; Cao Y; Zeng L; Zhang H; Rao Z; Li Y; Tao Z; Liu Z; Huang X
Virulence; 2024 Dec; 15(1):2367783. PubMed ID: 38937901
[TBL] [Abstract][Full Text] [Related]
56. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori.
Morihara F; Hifumi E; Yamada M; Nishizono A; Uda T
Biotechnol Bioeng; 2008 Jul; 100(4):634-43. PubMed ID: 18306426
[TBL] [Abstract][Full Text] [Related]
58. Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.
Xu C; Li ZS; Du YQ; Gong YF; Yang H; Sun B; Jin J
World J Gastroenterol; 2007 Feb; 13(6):939-44. PubMed ID: 17352028
[TBL] [Abstract][Full Text] [Related]
59. Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice.
Li HB; Zhang JY; He YF; Chen L; Li B; Liu KY; Yang WC; Zhao Z; Zou QM; Wu C
Vaccine; 2012 Dec; 31(1):120-6. PubMed ID: 23137845
[TBL] [Abstract][Full Text] [Related]
60. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
